REBLOZYL can only be purchased through authorized distributors for administration in physician offices, hospital outpatient facilities, institutions, Veterans Affairs, and the Department of Defense. The following distributors are authorized to sell REBLOZYL and are able to service qualified accounts.
Authorized distributor network
|McKesson Specialty Health||1-800-482-6700||1-800-289-9285|
|Institutions/hospital outpatient facilities|
|Puerto Rico hospitals and clinics|
|Cardinal Health P.R.||1-787-625-4200|
|Cesar Castillo, Inc.||1-787-641-5242
Extended dating terms may be available for REBLOZYL. Please contact your authorized distributor for more information.
Pursuant to the agreement with your authorized distributor, Celgene is committed to providing product within 1 business day of your order for REBLOZYL.
NDC and how supplied
National Drug Codes (NDC) and packaging information
|REBLOZYL injection 25 mg||25-mg lyophilized powder for solution for injection in a single-dose vial for reconstitution||59572-0711-01|
|REBLOZYL injection 75 mg||75-mg lyophilized powder for solution for injection in a single-dose vial for reconstitution||59572-0775-01|
The red zero converts the 10-digit NDC to the 11-digit NDC. Payer requirements regarding the use of NDCs may vary. Electronic data exchange generally requires use of the 11-digit NDC.
Billing and coding
|J0896||Injection, luspatercept-aamt, 0.25 mg|
|J3590||Not otherwise classified biologics|
|J9999||Not otherwise classified anti-neoplastic drugs|
|C9399||Unclassified or biologicals (hospital outpatient use only)|
|96372||Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular|
|96401||Chemotherapy administration, subcutaneous or intramuscular;
|1 unit = 0.25 mg||25-mg vial||100 units|
|75-mg vial||300 units|
|ICD-10-CM diagnosis codes for beta thalassemia|
|ICD-10-CM diagnosis codes for MDS|
|D46.1||Refractory anemia with ring sideroblasts|
|D46.A||Refractory cytopenia with multilineage dysplasia|
|D46.B||Refractory cytopenia with multilineage dysplasia and ring sideroblasts|
|D46.4||Refractory anemia, unspecified|
|D46.Z||Other myelodysplastic syndromes|
|D46.9||Myelodysplastic syndrome, unspecified|
CPT, Current Procedural Terminology; HCPCS, Healthcare Common Procedure Coding System; ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification.
CPT® codes and descriptions are copyright 2020 American Medical Association (AMA). All rights reserved. CPT® is a registered trademark of the AMA.
Depending on payer preferences for billing and coding, the required miscellaneous J code for claim submission may vary.
Therefore, the provider will want to confirm preference with payer prior to submitting.
Note the use of a miscellaneous C code (C9399) for when REBLOZYL is used in a hospital infusion center.
The 2020 version of ICD-10-CM took effect on October 1, 2019.
The information contained herein is not intended to provide specific coding and reimbursement advice for any specific patient or situation. You should check with your coding specialist to ensure appropriate submissions.